Certificates of analysis: a challenge to interpret - Anses - Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail Access content directly
Journal Articles EuroReference - Les Cahiers de la Référence Year : 2017

Certificates of analysis: a challenge to interpret

Abstract

The active pharmaceutical ingredient (API) in a medicinal product is the component that is responsible for the therapeutic effect. The personnel at the ANSES Fougères Laboratory routinely handle medicinal analytical standard and calculate their API content using the certificates of analysis provided by the manufacturer. However, meaningful data in these documents are not always easy to determine or may sometimes be absent: interpretation of these data can therefore result in assessment errors. Having identified this problem, the ANSES Laboratory has put forward an approach aimed at harmonising interpretation of certificates of analysis.
Fichier principal
Vignette du fichier
creff27.pdf (609.74 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

anses-01787685 , version 1 (07-05-2018)

Identifiers

Cite

Catherine Creff-Froger, Mélaine Bessiral, Marie-Pierre Fourmond, Céline Hedou, Agnès Perrin-Guyomard. Certificates of analysis: a challenge to interpret . EuroReference - Les Cahiers de la Référence, 2017, 3, pp.27-34. ⟨10.5281/zenodo.1172022⟩. ⟨anses-01787685⟩

Collections

ANSES
73 View
148 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More